Bill Gates does not expect coronavirus vaccine until the end of the year
Bill Gates does not believe any of the Covid-19 vaccines in development will receive FDA approval by the end of October, which would be bad news for President Donald Trump, who recently hinted at an effective vaccine to counter the pandemic ahead of November’s elections..
«None of the vaccines likely to receive US approval until late October», – said billionaire philanthropist to CNBC via videoconference last week.
Gates is more confident about the success of the vaccine trials by early next year, and even named one of the drug manufacturers, which he believes is, the most advanced.
«I really think once you get into, say, December or January, chances are that at least two or three (will ask for approval) – if there is efficiency», – said the Microsoft co-founder.
«So, we are in the third stage of testing. The only vaccine that, if all goes well, may require an emergency license by the end of October is Pfizer.».
The Gates Foundation, created by Gates and his wife Melinda, announced in March it will collaborate with several life sciences companies, including Pfizer, to develop a coronavirus vaccine. He also owns shares in Pfizer, Johnson & Johnson, Merck and others. In recent years, he has provided multimillion-dollar grants to Pfizer to develop various types of other vaccines..
Bill Gates: Here’s when we could expect a coronavirus vaccine
On Monday, Pfizer CEO Albert Bourla said his coronavirus vaccine, which is one of three vaccines in advanced testing in the West, could be circulated to Americans by the end of the year if it is found to be safe and effective. Other late-stage drug manufacturers that could potentially seek US approval are Moderna and Britain’s AstraZeneca..
«We do see good antibody levels in both Phase 1 and Phase 2, so we really hope», – said Bill Gates about these tests.
Russia and China have approved the emergency use of some of their own vaccines, although some Western healthcare professionals have taken the news from skepticism.
If approved by the FDA, Pfizer is ready to distribute «hundreds of thousands of doses», – Burla said, adding that the company should receive data on the latest stages of testing by the end of October. He said that Pfizer has already invested $ 1.5 billion in the development of a potential vaccine..
Over the weekend, Pfizer asked the FDA to expand its late-stage study to 44,000, up from 30,000..
The American pharmaceutical giant worked with the German pharmaceutical company BioNTech, and in July the US government announced it would pay them $ 1.95 billion to manufacture and supply 100 million doses of their vaccine if it is found to be safe and effective.
The deal was signed as part of Operation Warp Speed, organized by the Trump administration to accelerate the development and production of vaccines and drugs to combat coronavirus.
The Centers for Disease Control and Prevention said US states should be ready to distribute the vaccine as early as November 1, according to the statement Donald Trump on the possible availability of a ready-made effective vaccine on the eve of the elections. But this time period has raised concerns among some experts, who fear that the current security protocols will be rejected for political reasons..
According to Gates, the promise of leading vaccine developers gives him confidence that this will not happen..
«The good news is that top vaccine manufacturers today said they would not even apply for an emergency license until they have proof of effectiveness.», – he told CNBC. «We also have to go through all the safety measures so that people feel like they want to take part in the vaccination.».
In a public letter released on September 8, executives from nine major drug manufacturers have pledged not to seek approval for their vaccines until large clinical trials have proven their safety and effectiveness. The letter came amid reports that Trump was trying to bypass the FDA’s standard approval process to get approval for an expedited emergency use of an experimental vaccine, even if it hasn’t yet received full regulatory approval..
«In the interest of public health, we commit to always make the safety and well-being of vaccinated people our top priority.», – the letter says. It was signed by CEOs of Pfizer, AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Moderna, Novavax and Sanofi.